Brief: Interpace Biosciences Reports Qtrly Loss Per Share $2.32

Interpace Biosciences

25/06/2020 22:59

June 25 (Reuters) - Interpace Biosciences Inc  IDXG.O :
    * INTERPACE BIOSCIENCES ANNOUNCES FIRST QUARTER 2020
FINANCIAL AND
BUSINESS RESULTS
    * Q1 REVENUE $9.2 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$8.9
MILLION
    * SEES Q2 REVENUE $5.6 MILLION TO $6.0 MILLION
    * QTRLY LOSS PER SHARE $2.32
    * Q1 EARNINGS PER SHARE VIEW $-1.24 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX1x99Vz 
Further company coverage:  IDXG.O 

 ((Reuters.Briefs@thomsonreuters.com;))